Expert Insights From a Multidisciplinary Panel: A Self-Assessment Tool for SCLC

Author(s):

High variability in care delivery for small cell lung cancer (SCLC) across practice settings is a distinct challenge for care teams, with differences in the completeness of staging workups, timing of multidisciplinary referrals, and integration of palliative care being key areas that require standardized quality benchmarks. To meet this need, ACCC developed a quality care document and self-assessment tool for SCLC derived from insights from an expert-led Delphi panel.

Expert Insights From a Multidisciplinary Panel: A Self-Assessment Tool for SCLC

Considering it is the second most common cancer nationally in men and women and the leading cause of cancer-related death in the US, delivering timely, coordinated care for lung cancer is a top priority for cancer programs and practices.

These efforts start with screening and preventive care. Unfortunately, lung cancer has one of the lowest national screening rates of all cancers, with only about 18.7% of high-risk individuals screened in 2026. A variety of factors contribute to this reality, with patient shame about tobacco use and the fragmented nature of the screening process ranking high on the list. Yet even when eligible patients are screened, many get lost between the results and the follow-up care—demonstrating the need to think of screening as a continuum, rather than a single event.

For the continuum to work, the same coordination must carry past diagnosis into treatment, especially in aggressive cases of small cell lung cancer (SCLC). Making up about 15% of all lung cancers, SCLC tends to grow faster than non–small cell lung cancer and has often spread beyond the lungs by the time it is diagnosed. The delays that can stall the screening process—such as a missed follow-up, a slow referral, or a fragmented handoff between specialists—leave little margin for error. Even patients whose disease is caught through screening rely on a care team that can move them quickly from diagnosis to staging to treatment planning. To ensure that such cases are carefully coordinated and swiftly treated, effective processes and access to reliable benchmarks are paramount.

However, high variability in care delivery for SCLC across practice settings is a distinct challenge for care teams. Differences in the completeness of staging workups, timing of multidisciplinary referrals, and integration of palliative care highlight a clear need for standardized quality benchmarks to allow institutions to comprehensively assess their processes and adjust where necessary.

An Expert-Informed Self-Assessment Tool

To meet this need, the Association of Cancer Care Centers (ACCC), in partnership with the American Society for Radiation Oncology and LUNGevity, developed a quality care document and self-assessment tool for SCLC derived from insights from an expert-led Delphi panel.

First, ACCC gathered an advisory committee of clinicians with expertise spanning the full continuum of SCLC care to draft a collection of quality statements, later organized into six themes:

  • Diagnosis and staging
  • Patient education and communication
  • Curative treatment planning for limited-stage SCLC
  • Palliative treatment planning for extensive-stage SCLC
  • Treatment monitoring and care coordination
  • Supportive care.

The proposed statements were evaluated by a multidisciplinary Delphi panel of 24 participants, who narrowed the original 68 statements down to 50, all of which achieved 75% or greater agreement. ACCC members are encouraged to share this document with their teams and use it as a self-assessment tool to inform future quality improvement projects in identified areas of need. Programs that score highly across the assessment may consider contributing their insights to peer learning networks to share what practices are working well.

Shaping the Future of Lung Cancer Care

Throughout the document, several themes emerged around the importance of timeliness, care coordination, and supportive care. Several of the benchmarks set firm timelines for referrals to medical and radiation oncology and for completing staging, stressing the need for smooth care coordination to enable prompt initiation of treatment.

Across the six domains of statements, the strongest consensus is on multidisciplinary coordination and supportive care, rather than treatment planning. The three benchmarks with 100% agreement address smooth care transitions, monitoring for delayed adverse events, and regular pain assessment. In addition, several statements emphasize that palliative care and goals-of-care conversations must start early, especially for patients with extensive-stage disease.

As patient volumes grow across all cancer types, there is a distinct need for consistent, coordinated processes that guide patients from screening through survivorship. For SCLC, where the disease often moves faster than the systems built to treat it, that means honestly assessing where processes hold up and where patients may be falling through the cracks. ACCC's SCLC Quality Care Document gives teams a practical starting point: a shared set of expert-backed benchmarks, a clear way to rate current performance, and a framework for turning gaps into focused quality improvement projects.

This Lung Cancer Awareness Month, ACCC encourages its membership to use and share such resources with others to work toward a future where exceptional lung cancer care is accessible, consistent, and replicable across all care settings.

Read the full self-assessment here and find more resources on the ACCC Lung Cancer page.

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington